Anglikang Receives Drug Registration Certificate for Loxoprofen Sodium Gel Patch

Regulation
โดย 证券时报·Read original
Summary · why it matters

Anglikang announced that it has received the Drug Registration Certificate for Loxoprofen Sodium Gel Patch issued by the National Medical Products Administration. The drug is used for anti-inflammatory and analgesic treatment of conditions and symptoms such as osteoarthritis, muscle pain, and swelling and pain after trauma.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews